Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Bugworks Research Inc. logo — Path breaking solutions to large unmet needs in Antimicrobia...

Bugworks Research Inc.

Path breaking solutions to large unmet needs in Antimicrobial resistance (AMR) and immuno-oncology.

Founded 2014 India India 46 employees Venture round Total: $45.49M Biotechnology, Health Care +2

General Information

Company Name Bugworks Research Inc.
Founded Year 2014
Location India India
Employees 46
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Venture round
Business Model B2B, B2G
Revenue Model Licensing, Performance Based, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Bugworks Research Inc.. To contact Bugworks Research Inc., visit bugworksresearch.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bugworks Research Inc. compare?

A PDF of Bugworks Research Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bugworks Research Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Grant Received Oct 14, 2026

Bugworks Research Inc. received conditional approval for support under the Government of India's PRIP scheme for its BWC0977 and BWC2094 programs.

Bugworks Research Inc. a competitor of yours? Have our desk watch it

About Bugworks Research Inc.

Bugworks Research Inc., founded in 2014, is a dynamic player in the biotechnology, health care, life sciences, and pharmaceutical industries. Headquartered in India, the company is dedicated to addressing significant unmet needs through its innovative approaches in tackling Antimicrobial Resistance (AMR) and immuno-oncology.

With the slogan “Path breaking solutions to large unmet needs in Antimicrobial resistance (AMR) and immuno-oncology,” Bugworks is committed to making its highly differentiated medical assets both affordable and accessible globally. This mission positions them as a critical entity in the global health landscape, a factor that underscores their potential high-impact value.

The company recently secured a substantial $6.78M Venture Round investment on 08 March 2024, reflecting investor confidence in their distinctive capabilities and market-focused strategies. Though specific investor details remain undisclosed, this funding consolidates Bugworks’ traction and prospects for substantial growth in combating pressing health challenges.

Business keywords: Antimicrobial Resistance, Drug Discovery, Immuno-oncology, Pharmaceutical Assets, Novel Therapies, Innovative Solutions, Healthcare Access, Differentiated Assets, Biomedical Research, Infectious Disease, Therapeutic Development

Services & Products

Development of affordable and novel therapies
Discovery of antibacterial and oncology therapeutics
Research and development for drug discovery

Target Customers

Healthcare providers Pharmaceutical companies Biotech research institutions

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $6.78M -
08 Mar 2024
Series B $18.00M 9
3one4 Capital Global Brain Lightrock
3one4 Capital, Global Brain +7
09 Feb 2022
Series B $7.50M 3
Global Brain The University of Tokyo Edge Capital
Global Brain, The University of Tokyo Edge Capital +1
22 Apr 2020
Series A $9.00M 3
3one4 Capital The University of Tokyo Edge Capital
3one4 Capital, The University of Tokyo Edge Capital +1
13 Aug 2018
Grant $2.60M 1
CARB-X
CARB-X
26 Jul 2017
Venture Round Undisclosed 3
3one4 Capital Baxter Ventures
3one4 Capital, Baxter Ventures +1
24 Jul 2017
Venture Round $1.61M -
20 Nov 2015

Bugworks Research Inc. Alternatives & Competitors

View All Alternatives
Bugworks Research Inc. vs
Tetraphase Pharmaceuticals
Tetraphase Pharmaceuticals United States

Fighting against antimicrobial resistance is at the core of our technology and our people.

Grant
14 employees
Biopharma, Biotechnology
Compare Bugworks Research Inc. vs Tetraphase Pharmaceuticals
Bugworks Research Inc. vs
Differentiated Therapeutics Inc
Differentiated Therapeutics Inc United States

What if you could predict molecules to make the cause of disease disappear?

Seed
3 employees
Biotechnology, Health and Wellness
Compare Bugworks Research Inc. vs Differentiated Therapeutics Inc
Bugworks Research Inc. vs
Arrevus
Arrevus

Conquering antibiotic resistance by targeting critical diseases with innovative DPCs.

Grant
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Bugworks Research Inc.

Path breaking solutions to large unmet needs in Antimicrobial resistance (AMR) and immuno-oncology.
Bugworks Research Inc. was founded in 2014.
Bugworks Research Inc. is headquartered in India.
Bugworks Research Inc. operates in Biotechnology, Health Care, Life Sciences and Pharmaceutical. Its work centres on Antimicrobial Resistance, Drug Discovery, Immuno-oncology and Pharmaceutical Assets. Its customers include Healthcare providers, Pharmaceutical companies and Biotech research institutions.
Bugworks Research Inc. has a B2B and B2G business model. Its revenue comes from Licensing, Performance Based and Product Sales.
Bugworks Research Inc. has approximately 46 employees.
Bugworks Research Inc. has completed 7 funding rounds, raising a total of $45.49M. The latest funding stage is Venture round.
Bugworks Research Inc. offers: Development of affordable and novel therapies, Discovery of antibacterial and oncology therapeutics, Research and development for drug discovery.
Top alternatives and competitors to Bugworks Research Inc. include Tetraphase Pharmaceuticals, Differentiated Therapeutics Inc, Arrevus, Drug Discovery & Development, Chordia Therapeutics Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bugworks Research Inc. and Tetraphase Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bugworks Research Inc., https://bouncewatch.com/company/bugworks-research-inc, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout